Delafloxacin Meglumine 450 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 450 mg
Reference Brands: Baxdela (USA/EU)
Category: Antibiotics
Delafloxacin Meglumine is a Antibiotics product available as Tablets in strengths 450 mg. It corresponds to the reference brand Baxdela (USA/EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Delafloxacin, sold under the brand name Baxdela, is a broad-spectrum fluoroquinolone antibiotic used for the treatment of acute bacterial infections. It is primarily indicated for adults with acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible gram-positive and gram-negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Additionally, delafloxacin is approved for the treatment of community-acquired bacterial pneumonia (CABP) in adults caused by designated susceptible pathogens.
Delafloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication, transcription, and repair, thereby preventing bacterial growth and proliferation. It is available in both intravenous and oral formulations, allowing flexible treatment options and seamless transition from hospital to outpatient care. The medication is formulated as delafloxacin meglumine for IV administration and as delafloxacin tablets for oral use, ensuring optimal bioavailability and efficacy.
Developed and commercialized under the brand name Baxdela, delafloxacin is manufactured in compliance with international regulatory standards, including US FDA and EU GMP guidelines. It offers healthcare providers a potent and versatile option for managing complicated bacterial infections in adult patients.
Delafloxacin Meglumine — third party manufacturing & bulk supply
Delafloxacin Meglumine 450 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Delafloxacin Meglumine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Delafloxacin Meglumine →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Delafloxacin meglumine is used for the treatment of acute bacterial skin and skin structure infections caused by susceptible gram-positive and gram-negative bacteria. It is particularly effective against methicillin-resistant Staphylococcus aureus (MRSA) and other difficult-to-treat pathogens.
Delafloxacin meglumine is a synthetic fluoroquinolone antibacterial agent formulated as the meglumine salt for intravenous administration. It is produced through chemical synthesis and is not derived from any biological or natural source.
Delafloxacin meglumine is marketed under the trade name Baxdela.
Delafloxacin meglumine was originally developed by Melinta Therapeutics. The branded product Baxdela has been manufactured and commercialized by Melinta and its authorized partners, with generic manufacturers also supplying the product in various markets.
The complete generic name is delafloxacin meglumine.
The brand name of delafloxacin meglumine is Baxdela.
Delafloxacin meglumine is manufactured in multiple countries depending on the supplier and market, including facilities in the USA, Europe, and India, in compliance with international regulatory standards such as US FDA and EU GMP.
Related Products
Rifaximin
Strength:
100 mg/5 mL, 200 mg, 550 mg
Form: Tablet / Oral Suspension
Reference Brands: Xifaxan (USA), Targaxan (EU), Normix (LATAM)
View Details
Ceftaroline
Strength:
600 mg
Form: Injection
Reference Brands: Teflaro (USA), Zinforo (EU)
View Details
Quick Response Guaranteed | Verified Suppliers
